Foto del docente

Pier Luigi Zinzani

Full Professor

Department of Experimental, Diagnostic and Specialty Medicine - DIMES

Academic discipline: MED/15 Blood Diseases

Curriculum vitae

    • Born in Arenzano (GE) 9th March, 1959
    • High School Qualification, in 1978
    • Graduated in Medicine and Surgery, with honours at the University of Bologna, in 1984
    • Medical Licence registration Number: 12457
    • Obtained the Speciality in Hematology, with honours at the University of Bologna, in 1987
    • Awarded a “Post-Doctoral Fellowship in Medical Physics” released by the “Roger Williams Cancer Ospitale” of Providence (USA) in 1989
    • Resident physician at the Institute of Hematology and Medical Oncology “L. e A. Seràgnoli” since 1990
    • Member of the Italian Society of Hematology since 1986
    • Member of the Italian Society of Experimental Hematology since 1987
    • Member of the American Society of Hematology since 1989
    • Member of the American Society of Clinical Oncology from 1989
    • 480 scientific publications particularly devoted to Hodgkin’s disease, non-Hodgkin’s lymphomas and hary cell leukemia.
    • Associated professor since November 2002 at the Institute of Hematology “L. e A. Seràgnoli” U.O. / Ematologia - Pad. 8 - S. Orsola, Policlinico S. Orsola Malpighi, Via Massarenti, 9 40138 Bologna Italy
    • From Novembre 2013 to November 2015, President of FIL, Fondazione Italiana Linfomi onlus.
    • Since 2002 involved as investigator in 150 national and international clinical trials according to IGH-GCP and FDA regulations.
    • I confirm that I have experience of conducting clinical studies to ICH GCP standard

      I confirm that I have attended a recognized commercial ICH GCP training course within the last five years with relative certificate.

    • I confirm that I have attended ICH GCP presentations provided by a clinical trial sponsor company or CRO (eg during an Investigator’s Meeting) within the last five years.
    • Since 2014 Associate Editor for Annals of Oncology

Latest news

At the moment no news are available.